ResMed Released New Sleep Apnea Screening Tool
The questionnaire aims to improve diagnostic accuracy by focusing on symptoms unique to female patients.
Updated on Sept. 28, 2026 in Sleep Disorders
Live Poll
Should medical diagnostic tools be specifically tailored to account for gender differences in symptom presentation?
ResMed has introduced a new Women's Sleep Assessment tool designed to identify obstructive sleep apnea in women. Developed by an all-female team, the tool addresses the tendency for traditional screening methods to overlook symptoms prevalent in female patients.
Why it matters
Traditional diagnostic tools often lack the sensitivity to detect sleep apnea in women, who frequently present with different symptoms than men. This screening addresses common comorbidities and life stages that contribute to misdiagnosis.
A 437-participant pilot study grounded the tool's development, which utilized input from 35 global sleep experts. Projections estimate that 30.4 million women will be living with obstructive sleep apnea by 2050.
The players
ResMed
ResMed is a medical device company that specializes in cloud-connected devices for the treatment of sleep apnea, COPD, and other chronic diseases.
The details
The questionnaire centers on specific female-reported symptoms, including fatigue, insomnia, anxiety, and depression, while utilizing the oxygen desaturation index as a key risk metric. It specifically accounts for higher odds of mild sleep apnea in peri-menopausal and post-menopausal women compared to those who are pre-menopausal.
Timeline
The tool was released in September 2026.
Experts project 30.4 million women will have obstructive sleep apnea by 2050.
The Big Picture
This tool integrates the oxygen desaturation index into a new, female-specific assessment framework to improve upon existing diagnostic standards. It marks a departure from legacy models that primarily characterized sleep apnea through male-centric symptoms like diabetes.
Women experiencing unexplained fatigue, anxiety, or insomnia can now utilize a screening method tailored to female-specific symptoms. This development may lead to earlier clinical intervention and more accurate diagnostic results for those previously missed by standard tests.
The takeaway
Patients who struggle with symptoms like insomnia or anxiety should discuss their sleep quality with a provider who understands how sleep apnea presents in women. Using gender-specific assessment tools can help ensure that mild conditions are identified before they escalate.
Further reading
For more information on diagnostic advancements, visit the Sleep Disorders section.
Source note: This article includes information reported by Sleep Review.
Live Poll
Should medical diagnostic tools be specifically tailored to account for gender differences in symptom presentation?
